HIV-1 RT 476-484 (HLA-A*02:01)

HIV-1 RT 476-484 (HLA-A*02:01)
€50.00 *

Prices plus VAT plus shipping costs

Delivery time 2-3 days
sterile and endotoxin free Delivery Format:
The product is supplied freeze dried as trifluoracetate salt

Amount in mg:

make your choice

  • EP08035_1
ILKEPVHGV is a linear peptidic epitope studied as part of Gag-Pol polyprotein from Human... more
Product information "HIV-1 RT 476-484 (HLA-A*02:01)"
ILKEPVHGV is a linear peptidic epitope studied as part of Gag-Pol polyprotein from Human immunodeficiency virus 1. HIV pol peptide ILKEPVHGV (HLA-A*0201) for stimulation of human HIV pol-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*02:01 allele. This is a reverse transcriptase (RT) epitope (Pol residues 476-484). Within HIV-1 RT the peptide appears to be the dominant HLA A*0201-restricted epitope. Was used to investigate possible mechanisms behind HIV-1 escape from CTL. IV9 is the actual epitope processed and presented in HIV-1-infected cell linesILKEPVHGV is a linear peptidic epitope studied as part of Gag-Pol polyprotein from Human immunodeficiency virus 1. HIV pol peptide ILKEPVHGV (HLA-A*0201) for stimulation of human HIV pol-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*02:01 allele. This is a reverse transcriptase (RT) epitope (Pol residues 476-484). Within HIV-1 RT the peptide appears to be the dominant HLA A*0201-restricted epitope. Was used to investigate possible mechanisms behind HIV-1 escape from CTL. IV9 is the actual epitope processed and presented in HIV-1-infected cell linesILKEPVHGV is a linear peptidic epitope studied as part of Gag-Pol polyprotein from Human immunodeficiency virus 1. HIV pol peptide ILKEPVHGV (HLA-A*0201) for stimulation of human HIV pol-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*02:01 allele. This is a reverse transcriptase (RT) epitope (Pol residues 476-484). Within HIV-1 RT the peptide appears to be the dominant HLA A*0201-restricted epitope. Was used to investigate possible mechanisms behind HIV-1 escape from CTL. IV9 is the actual epitope processed and presented in HIV-1-infected cell linesILKEPVHGV is a linear peptidic epitope studied as part of Gag-Pol polyprotein from Human immunodeficiency virus 1. HIV pol peptide ILKEPVHGV (HLA-A*0201) for stimulation of human HIV pol-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*02:01 allele. This is a reverse transcriptase (RT) epitope (Pol residues 476-484). Within HIV-1 RT the peptide appears to be the dominant HLA A*0201-restricted epitope. Was used to investigate possible mechanisms behind HIV-1 escape from CTL. IV9 is the actual epitope processed and presented in HIV-1-infected cell lines

 
Sequence:ILKEPVHGV
Gene:gag-pol
Delivery: 2-3 days
C-Terminus:OH
N-Terminus:H
Purity:95%
Amount:1 mg
Counter Ion:TFA
Protein:Gag-Pol polyprotein
Species:HIV-1
Allele:HLA-A*02:01
Application :Flow Cytometry
Indication :AIDS (HIV)
Dokumente - Protokolle - Downloads more
Viewed